Global researchers planning to build a career in cancer science now have a powerful funding route to pursue a PhD in Australia. The Leukaemia Foundation PhD Scholarship 2026 has officially opened to support the next generation of scientists and health professionals working to advance blood cancer research, prevention, treatment, and patient outcomes.
This competitive PhD funding opportunity is designed for early-career researchers who want to contribute to real-world medical breakthroughs. By investing in impactful research projects and nurturing scientific talent, the Leukaemia Foundation continues to strengthen Australia’s research ecosystem and support innovations that directly benefit people living with blood cancer worldwide.
With a focus on high-impact and priority-driven research areas, this scholarship aims to empower talented candidates to undertake doctoral research that can transform diagnosis, treatment pathways, and survivorship care for blood cancer patients.
Funding That Fuels Real Medical Impact
If you are planning to pursue a PhD in blood cancer research, this scholarship offers substantial financial backing to help you focus fully on your research journey.
Selected candidates will receive a total funding package of $150,000 over three years for full-time PhD study. This funding is designed to support innovative research projects that align with the Leukaemia Foundation’s strategic priority areas, including early detection, advanced therapies, and implementation science.
The scholarship also provides a strong professional development environment, allowing scholars to collaborate with leading supervisors, gain access to mentorship, and build long-term careers in health and medical research. With dedicated support and structured milestones, applicants can focus on producing impactful research outcomes that benefit patients and healthcare systems globally.
Who Can Apply for This PhD Research Scholarship?
If you are aiming to build a research career in blood cancer or related health sciences, this opportunity is tailored for you. Ideal candidates include:
- Australian citizens or permanent residents of Australia
- Applicants able to begin a PhD in mid-2026 or early-2027 at an eligible Australian university or research institute
- Candidates supported by an experienced primary supervisor and supervisory team
- Researchers ready to commit full-time to their PhD project
- Applicants with academic or professional backgrounds in health and medical science, clinical care, pharmacy, nursing, allied health, or public health
- Projects aligned with priority research areas such as prevention, diagnostics, therapies, or implementation science
- Research proposals demonstrating clear patient, healthcare, or community impact
Applicants must ensure their proposed project is achievable within the scholarship period and includes clear milestones, outcomes, and stakeholder involvement.
Why You Should Consider Studying Under This Institute?
If you want your PhD to create real-world healthcare impact, this scholarship places you at the center of meaningful research innovation. By joining this program, you gain the opportunity to work on priority-driven projects that directly influence blood cancer care, treatment advancements, and survivorship strategies.
You will also benefit from strong mentorship, structured research guidance, and the chance to collaborate with leading experts across Australia’s top universities and research institutes. This environment not only strengthens your academic profile but also prepares you for long-term roles in global health research, clinical science, and policy innovation.
Apply: https://www.leukaemia.org.au/research-and-advocacy/research-hub/lf-phd-scholarship/
Application Deadline for Leukaemia Foundation PhD Scholarship 2026
The last date to apply for the Leukaemia Foundation PhD Scholarship is 13 April 2026 at 11:59pm AEST. Applications will open on 9 March 2026, and selected candidates are expected to be notified in June 2026, with scholarship commencement scheduled for July 2026 or January 2027.